Key takeaway
In 609 adults without diabetes, 12-month weight change was -5.3 kg on a healthy low-fat diet and -6.0 kg on a healthy low-carbohydrate diet, a 0.7 kg gap (95% CI -0.2 to 1.6 kg) that was not statistically significant. A tested genotype pattern and baseline insulin secretion did not predict who did better on which diet. Both arms received 22 coaching sessions and 79% finished, so this describes coached dieting in adults aged 18 to 50.
Study design
Randomised trial
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
The research question
Changing what you eat is central to losing weight, yet the authors state that no single dietary strategy has proved consistently better for the general population. Earlier research suggested that a person's genotype, or how their body handles insulin and glucose, might change how they respond to a given diet. If that were true, 'which diet suits whom' would have a testable answer. The DIETFITS trial set out to compare a healthy low-fat diet with a healthy low-carbohydrate diet on 12-month weight change, and to test whether a pattern across 3 gene variants, or insulin secretion 30 minutes after a glucose challenge, explains who loses more on which diet.
Who and how
DIETFITS (Diet Intervention Examining The Factors Interacting with Treatment Success) was a randomised clinical trial of 609 adults aged 18 to 50 years without diabetes and with a body mass index (BMI) between 28 and 40. Enrolment ran from January 29, 2013 through April 14, 2015, and the final follow-up was on May 16, 2016. Participants had a mean age of 40 years (SD 7), 57% were women, and mean BMI was 33 (SD 3). Each person was randomly assigned to a healthy low-fat diet (HLF, n = 305) or a healthy low-carbohydrate diet (HLC, n = 304) for 12 months. Health educators delivered the behaviour programme in 22 diet-specific small-group sessions spread over the year. The sessions aimed at the lowest fat or carbohydrate intake each person could keep up long term and stressed diet quality. Full details are not in the abstract, which does not name the country or the study sites.
The primary outcome was weight change at 12 months, compared between the two diets. The authors also tested two ideas about who should do better on which diet. The first was a genotype pattern built from 3 single-nucleotide polymorphisms (single-letter variations in the DNA code): 244 participants (40%) carried the pattern labelled low-fat and 180 (30%) the one labelled low-carbohydrate. The second was insulin secretion, measured as INS-30, the blood insulin concentration 30 minutes after a glucose challenge (mean 93 μIU/mL at baseline). Each idea was tested as an interaction, meaning whether the gap between the diets changed with genotype pattern or INS-30. Average macronutrient shares over the 12 months and adverse events were also reported. The abstract does not describe the statistical model, how missing data were handled, or how food intake was measured.
What it found
- 1Both diets produced about the same average weight loss. At 12 months the HLF group had changed by -5.3 kg and the HLC group by -6.0 kg, a mean between-group difference of 0.7 kg (95% CI -0.2 to 1.6 kg) that was not statistically significant.
- 2The groups did end up eating differently. Mean 12-month intake was 48% carbohydrate on HLF versus 30% on HLC, 29% versus 45% fat, and 21% versus 23% protein, so the contrast was mostly carbohydrate against fat with protein similar.
- 3The tested genotype pattern did not tell people which diet to choose. There was no significant diet-by-genotype-pattern interaction with 12-month weight loss (P = 0.20), even though 244 participants (40%) had the low-fat pattern and 180 (30%) the low-carbohydrate pattern.
- 4Baseline insulin secretion did not help either. The diet-by-INS-30 interaction with 12-month weight loss was not significant (P = 0.47).
- 5Of the 609 people randomised, 481 (79%) completed the trial. There were 18 adverse events or serious adverse events, spread evenly across the two diet groups.
Limits & uncertainty
- 1The authors limit their conclusion to these two common weight-loss diet approaches and to the two predisposing factors they hypothesised. Other gene variants, other insulin measures and other diets were not tested, so a null result here does not rule out every possible predictor.
- 2Our observation: every participant received 22 coached group sessions, and everyone was aged 18 to 50 years, free of diabetes and had a BMI of 28 to 40. The results may not carry over to older adults, people with diabetes or higher BMI, or dieting without that kind of support.
- 3Our observation: 481 of 609 participants (79%) finished, so the 12-month averages depend on how people who left were handled, which the abstract does not say. The low-carbohydrate arm also still averaged 30% of intake from carbohydrate, so it does not speak to stricter low-carbohydrate plans.
- 4Our observation: the confidence interval for the main difference (-0.2 to 1.6 kg) leaves room for a small gap, mostly in favour of the low-carbohydrate diet. Interaction tests generally have less statistical power than the main comparison, and the abstract reports group averages only, not how widely individual weight changes varied.
What to take from it
For adults in this age and BMI range, this trial gives no sign that choosing a healthy low-fat plan over a healthy low-carbohydrate plan, or the reverse, changes average weight loss over a year when both are coached and aimed at the lowest intake you can keep up. The more useful question is which pattern you can stick with and still eat well. The trial also found no support for using this genotype pattern or an insulin-response test to pick a diet.
It does not show that everyone loses the same amount, that stricter versions of either diet would perform the same, or that either diet is right for someone with diabetes or on glucose-lowering drugs. This is fairly solid evidence for average weight change at 12 months in similar adults, from a randomised design with 79% completion, and it is silent on health outcomes beyond weight. Anyone with a medical condition should settle diet changes with their clinician.
Reading your own data
Weight is the outcome this trial used, so weigh yourself at a fixed time on the same scale and judge the 7-day average against the previous weeks rather than any single reading, over many weeks. A food-log app that reports carbohydrate and fat shares can show whether your intake actually separated from your old pattern, which matters because the two trial groups did differ in what they ate. Steps, heart rate and sleep from a wearable were not part of this result and will not tell you which diet suits you.
How to read this evidence
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Sources & attribution
Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial
JAMA · 2018-02-20
DOI: 10.1001/jama.2018.0245 ↗PubMed · 29466592 ↗MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

